News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) Cuts A $190 Million Settlement Deal Over Epilepsy Drug Neurontin



4/21/2014 4:27:25 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - Pfizer Inc has agreed to pay $190 million to settle a class-action lawsuit alleging the pharmaceutical company took steps to delay market entry of generic versions of its epilepsy drug Neurontin, according to court documents filed on Monday.

Lawyers representing a class of Neurontin purchasers disclosed the terms of the settlement in a motion filed in New Jersey federal court seeking approval of the deal.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters


comments powered by Disqus
Reuters
   
Epilepsy

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES